A comprehensive view of Epidemic / Pandemic. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Printing & Publishing Market Intelligence Service.
Novavax's updated non-mRNA COVID-19 vaccine, Nuvaxovid XBB.1.5, now available in UK for 2024 vaccination season following receipt of wholesale license and green book update
Published:
April 18, 2024
by Novavax Inc.
|
Abbott reports Q1 organic sales growth, excluding COVID-19 related sales, of 10.8%; medical device and established pharmaceutical sales grew 14% during the quarter
Published:
April 17, 2024
by FierceBiotech
|
China Petroleum and Chemicals 15 Apr 24 - INDUSTRY SNAPSHOTS
Published:
April 15, 2024
by Acquisdata Industry Snapshot
|
Pfizer and BioNTech get temporary reprieve in patent dispute with Moderna, allowing more time for the Patent Trial and Appeal Board to review challenges; Pfizer and BioNTech’s COVID-19 vaccine to remain on the market despite lawsuit
Published:
April 15, 2024
by FiercePharma
|
Global ocean freight rates have been falling since 2022 following pandemic; experts warn that factors, such as expected increase in oil, fuels used for ocean shipping and problems in Panama Canal, could lead to increases in freight rates in coming months
Published:
April 15, 2024
by CE Noticias Financieras
|
Ask us about our Printing & Publishing market view